Stock Market Reviews

Read and share opinions on LAB (Standard BioTools Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
  Nov 10, 2025
• Standard BioTools (LAB): Losses Continue While Low Price-to-Sales Spurs Value Debate
  Nov 5, 2025
• Standard BioTools: Q3 Earnings Snapshot
  Nov 4, 2025
• Standard BioTools Reports Third Quarter 2025 Financial Results
  Nov 4, 2025
• Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
  Oct 21, 2025
• Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
  Sep 3, 2025
• Standard BioTools Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
  Aug 13, 2025
• Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates
  Aug 11, 2025
• Standard BioTools: Q2 Earnings Snapshot
  Aug 11, 2025
• Standard BioTools Reports Second Quarter 2025 Financial Results
  Aug 11, 2025
• The past five years for Standard BioTools (NASDAQ:LAB) investors has not been profitable
  Aug 11, 2025
• Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study
  Aug 6, 2025
• Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
  Jul 21, 2025
• Illumina to Acquire SomaLogic for $350 Million, Expanding into Proteomics and Precision Medicine
  Jul 3, 2025
• Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
  Jun 25, 2025
• Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series
  May 30, 2025
• Standard BioTools First Quarter 2025 Earnings: Beats Expectations
  May 8, 2025